Medable launched its Agentic Accelerator Program to help life sciences teams deploy agentic AI across clinical development workflows. The program offers onboarding, integration support, governance, and change management, positioning it as a response to an industry gap where only a minority of leaders have scaled AI beyond pilots. Medable says the program is designed to shorten “time to value” by providing dedicated support from AI clinical development experts and forward-deployed engineers. It is available to Medable Agent Studio customers, with the platform supporting no-code agent creation, human-in-the-loop oversight, and GxP-ready compliance controls. For sponsors and CROs, the initiative targets not just automation, but auditability and regulatory alignment via built-in governance controls and connectors across clinical and enterprise systems. The announcement underscores that AI implementation in regulated development is increasingly treated as an engineering-plus-governance problem, not a standalone software rollout.